Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.
Clinical trial NCT06234956 · COMPLETED
Trial details
- NCT number
- NCT06234956
- Sponsor
- Hipra Scientific, S.L.U
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-08
- Primary completion
- 2025-09-09
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.